{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:31:29Z","timestamp":1786473089489,"version":"build-2736575974"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hubei Provincial Natural Science Foundation Project","award":["2024AFD143"],"award-info":[{"award-number":["2024AFD143"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the role of Nesprin-1 in the development and progression of isoproterenol (ISO)-induced heart failure (HF) and to elucidate the underlying molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HF was induced in mice via daily intraperitoneal injections of ISO (5 mg\/kg\/day) for 24 consecutive days. Cardiac function was evaluated using transthoracic echocardiography to measure diastolic left ventricular diameters (LVDd), systolic left ventricular end diameter (LVDs), ejection fraction (EF), and fractional shortening (FS). The HF model was validated through gross cardiac observation, WGA staining, and Western blot analysis of B-type Natriuretic Peptide (BNP). Histological changes were assessed via H&amp;E staining. Oxidative stress was evaluated by quantifying malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. The expression and localization of Nesprin-1, Connexin 43 (Cx43), DNA damage markers (53BP1, \u03b3H2AX), and epigenetic markers (H3K9me3, H3K27me3) were examined using immunofluorescence and Western blotting. The activation of the ERK signaling pathway was also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the control group, ISO-induced HF mice exhibited significant increases in body\/heart weight and cardiomyocyte cross-sectional area, alongside elevated BNP expression (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Echocardiography revealed increased LVDd and LVDs with markedly reduced EF and FS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Histopathologically, the model group showed disorganized myocardial structures, vascular proliferation, and hemorrhage. Crucially, Nesprin-1 expression was significantly downregulated (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), accompanied by abnormal nuclear membrane localization and morphological changes in myocardial cell nuclei. Significant nuclear distortions in the model group included increased area, perimeter, and length-to-diameter ratio alongside reduced roundness. Parallel to these changes, the model group showed increased malondialdehyde levels and decreased superoxide dismutase activity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Notably, several markers showed highly significant differences\u00a0(\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), including the downregulation of Connexin 43 and the upregulation of DNA damage markers \u03b3H2AX and 53BP1. Significant epigenetic remodeling, characterized by elevated H3K9me3 and H3K27me3, was also observed. Finally, a marked hyperactivation of the ERK signaling pathway was recorded, also reaching statistical significance at (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that the downregulation of Nesprin-1 is closely associated with HF pathogenesis. In the ISO-induced HF model, diminished Nesprin-1 expression correlated with disrupted nuclear homeostasis, reduced Cx43 expression, severe oxidative stress, DNA damage accumulation, and epigenetic disturbances, which may be mediated through the abnormal activation of the ERK signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354482","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:37:26Z","timestamp":1786469846000},"page":"e0354482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Role of Nesprin1 in isoproterenol-induced heart failure: Insights into pathogenesis and therapeutic implications"],"prefix":"10.1371","volume":"21","author":[{"given":"Qin","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyuanzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengpan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-5692","authenticated-orcid":true,"given":"Lin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"1","key":"pone.0354482.ref001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure","volume":"6","author":"E Tanai","year":"2015","journal-title":"Compr Physiol"},{"issue":"6","key":"pone.0354482.ref002","first-page":"523","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"75","author":"TA McDonagh","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"4","key":"pone.0354482.ref003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal Definition and Classification of Heart Failure","volume":"27","author":"B Bozkurt","year":"2021","journal-title":"Journal of Cardiac Failure"},{"issue":"5","key":"pone.0354482.ref004","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"CD Kemp","year":"2012","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"pone.0354482.ref005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10741-021-10137-2","article-title":"Current and emerging drug targets in heart failure treatment","volume":"27","author":"N Ghionzoli","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"17","key":"pone.0354482.ref006","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"G Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"pone.0354482.ref007","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"B Shahim","year":"2023","journal-title":"Card Fail Rev"},{"issue":"8","key":"pone.0354482.ref008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4330\/wjc.v12.i8.373","article-title":"Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers","volume":"12","author":"JA Borovac","year":"2020","journal-title":"World J Cardiol"},{"issue":"2","key":"pone.0354482.ref009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/cells10020457","article-title":"Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?","volume":"10","author":"L Bencivenga","year":"2021","journal-title":"Cells"},{"issue":"6","key":"pone.0354482.ref010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00395-019-0750-1","article-title":"Carotid baroreceptor stimulation suppresses ventricular fibrillation in canines with chronic heart failure","volume":"114","author":"J Wang","year":"2019","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"pone.0354482.ref011","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/ATVBAHA.118.311992","article-title":"Transthoracic pulmonary artery denervation for pulmonary arterial hypertension","volume":"39","author":"Y Huang","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"pone.0354482.ref012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-023-10345-y","article-title":"The sympathetic nervous system in heart failure revisited","volume":"29","author":"F Triposkiadis","year":"2024","journal-title":"Heart Fail Rev"},{"issue":"8","key":"pone.0354482.ref013","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/cvr\/cvab222","article-title":"Central and peripheral sympathetic activation in heart failure","volume":"118","author":"G Grassi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"pone.0354482.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartjsupp\/suac030","article-title":"Sympathetic activation in heart failure","volume":"24","author":"E Gronda","year":"2022","journal-title":"Eur Heart J Suppl"},{"issue":"7","key":"pone.0354482.ref015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/ijms17070797","article-title":"Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension","volume":"17","author":"N Mu\u00f1oz-Durango","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0354482.ref016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10741-019-09855-5","article-title":"The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure","volume":"25","author":"NR Pugliese","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"1","key":"pone.0354482.ref017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"NS Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"key":"pone.0354482.ref018","article-title":"The renin-angiotensin-aldosterone system: a specific target for hypertension management","volume":"12","author":"MR Weir","year":"1999","journal-title":"Am J Hypertens"},{"issue":"41","key":"pone.0354482.ref019","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030904","article-title":"The angiotensin receptor and neprilysin inhibitor, LCZ696, in heart failure: A meta-analysis of randomized controlled trials","volume":"101","author":"Y Chen","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"pone.0354482.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"PA Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0354482.ref021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11906-016-0660-7","article-title":"Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies","volume":"18","author":"K Lachowska","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"pone.0354482.ref022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15420\/cfr.2016:22:2","article-title":"Neurohormonal blockade in heart failure","volume":"3","author":"TG von Lueder","year":"2017","journal-title":"Card Fail Rev"},{"issue":"4","key":"pone.0354482.ref023","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10741-021-10137-2","article-title":"Current and emerging drug targets in heart failure treatment","volume":"27","author":"N Ghionzoli","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"1","key":"pone.0354482.ref024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200509124","article-title":"Coupling of the nucleus and cytoplasm: role of the LINC complex","volume":"172","author":"M Crisp","year":"2006","journal-title":"J Cell Biol"},{"issue":"6","key":"pone.0354482.ref025","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1042\/BST20110658","article-title":"The LINC complex and human disease","volume":"39","author":"P Meinke","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"pone.0354482.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvac066.138","article-title":"Investigating novel roles for nesprin-1 and the LINC complex in Dilated Cardiomyopathy","volume":"118","author":"S De Silva","year":"2022","journal-title":"Cardiovascular Research"},{"issue":"12","key":"pone.0354482.ref027","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/hmg\/ddx116","article-title":"Novel nesprin-1 mutations associated with dilated cardiomyopathy cause nuclear envelope disruption and defects in myogenesis","volume":"26","author":"C Zhou","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"pone.0354482.ref028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.RES.73.1.193","article-title":"Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells","volume":"73","author":"CM Shanahan","year":"1993","journal-title":"Circ Res"},{"issue":"1","key":"pone.0354482.ref029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12881-017-0424-5","article-title":"A novel SYNE1 gene mutation in a Chinese family of Emery-Dreifuss muscular dystrophy-like","volume":"18","author":"Z Chen","year":"2017","journal-title":"BMC Med Genet"},{"issue":"3","key":"pone.0354482.ref030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCRESAHA.114.301236","article-title":"Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease","volume":"114","author":"MJ Stroud","year":"2014","journal-title":"Circ Res"},{"issue":"1","key":"pone.0354482.ref031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41420-020-00327-6","article-title":"Apoptotic stress induces Bax-dependent, caspase-independent redistribution of LINC complex nesprins","volume":"6","author":"L Lindenboim","year":"2020","journal-title":"Cell Death Discov"},{"issue":"3","key":"pone.0354482.ref032","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ijms22030987","article-title":"Importance of Cx43 for Right Ventricular Function","volume":"22","author":"K Boengler","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0354482.ref033","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11033-019-05184-w","article-title":"Nesprin-1 impact on tumorigenic cell phenotypes","volume":"47","author":"I Sur-Erdem","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"pone.0354482.ref034","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCRESAHA.123.322620","article-title":"Spatial multiplexed protein profiling of cardiac ischemia-reperfusion injury","volume":"133","author":"L Yao","year":"2023","journal-title":"Circ Res"},{"key":"pone.0354482.ref035","doi-asserted-by":"crossref","first-page":"104108","DOI":"10.1016\/j.ebiom.2022.104108","article-title":"Targeting miR-30d reverses pathological cardiac hypertrophy","volume":"81","author":"J Li","year":"2022","journal-title":"EBioMedicine"},{"issue":"9","key":"pone.0354482.ref036","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/cdd.2015.12","article-title":"Nesprin-2-dependent ERK1\/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing","volume":"22","author":"DT Warren","year":"2015","journal-title":"Cell Death Differ"},{"issue":"10440","key":"pone.0354482.ref037","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"F G B D R","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"pone.0354482.ref038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"G Savarese","year":"2017","journal-title":"Card Fail Rev"},{"issue":"10","key":"pone.0354482.ref039","article-title":"Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies","volume":"15","author":"F Sapna","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"pone.0354482.ref040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","article-title":"Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction [J","volume":"7","author":"A Aimo","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"11","key":"pone.0354482.ref041","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides","volume":"17","author":"JP Goetze","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"15","key":"pone.0354482.ref042","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/heartjnl-2018-314173","article-title":"Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction","volume":"105","author":"K Salah","year":"2019","journal-title":"Heart"},{"issue":"41","key":"pone.0354482.ref043","doi-asserted-by":"crossref","first-page":"31986","DOI":"10.1074\/jbc.M004775200","article-title":"Syne-1, a dystrophin- and Klarsicht-related protein associated with synaptic nuclei at the neuromuscular junction","volume":"275","author":"ED Apel","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0354482.ref044","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1042\/BST20221541","article-title":"Nesprin-1: novel regulator of striated muscle nuclear positioning and mechanotransduction","volume":"51","author":"S De Silva","year":"2023","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"pone.0354482.ref045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/hmg\/ddac179","article-title":"Nesprin-1 LINC complexes recruit microtubule cytoskeleton proteins and drive pathology in Lmna-mutant striated muscle","volume":"32","author":"EL Leong","year":"2023","journal-title":"Hum Mol Genet"},{"key":"pone.0354482.ref046","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1242\/jcs.01642","article-title":"Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle","volume":"118","author":"Q Zhang","year":"2005","journal-title":"J Cell Sci"},{"key":"pone.0354482.ref047","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2013.6","article-title":"Nesprins: from the nuclear envelope and beyond","volume":"15","author":"D Rajgor","year":"2013","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"pone.0354482.ref048","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12964-024-01593-y","article-title":"Nesprin proteins: bridging nuclear envelope dynamics to muscular dysfunction","volume":"22","author":"Z Zi-Yi","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"9","key":"pone.0354482.ref049","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/ijms20092164","article-title":"ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy","volume":"20","author":"S Gallo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0354482.ref050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fphar.2015.00149","article-title":"Extracellular signal-regulated kinases 1\/2 as regulators of cardiac hypertrophy","volume":"6","author":"M Mutlak","year":"2015","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0354482.ref051","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40659-021-00342-6","article-title":"Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies","volume":"54","author":"M Ramos-Kuri","year":"2021","journal-title":"Biol Res"},{"issue":"10","key":"pone.0354482.ref052","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells10102509","article-title":"ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer","volume":"10","author":"R Sugiura","year":"2021","journal-title":"Cells"},{"issue":"1","key":"pone.0354482.ref053","article-title":"Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates [J","volume":"16","author":"X Desch\u00eanes-Simard","year":"2023","journal-title":"]. Cancers (Basel)"},{"issue":"1","key":"pone.0354482.ref054","article-title":"Synergistic anticancer effect by targeting CDK2 and EGFR-ERK signaling","volume":"223","author":"J Wu","year":"2024","journal-title":"J Cell Biol"},{"key":"pone.0354482.ref055","doi-asserted-by":"crossref","first-page":"671887","DOI":"10.3389\/fcell.2021.671887","article-title":"Syne2b\/Nesprin-2 Is Required for Actin Organization and Epithelial Integrity During Epiboly Movement in Zebrafish","volume":"9","author":"Y-L Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"pone.0354482.ref056","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949910","article-title":"Nesprin-2 accumulates at the front of the nucleus during confined cell migration","volume":"21","author":"PM Davidson","year":"2020","journal-title":"EMBO Rep"},{"issue":"12","key":"pone.0354482.ref057","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11886-019-1224-7","article-title":"Lamin A\/C cardiomyopathy: implications for treatment","volume":"21","author":"SN Chen","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"pone.0354482.ref058","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/dvdy.427","article-title":"A CRISPR\/Cas9 zebrafish lamin A\/C mutant model of muscular laminopathy","volume":"251","author":"HA Nicolas","year":"2022","journal-title":"Dev Dyn"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:37:36Z","timestamp":1786469856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354482"}},"subtitle":[],"editor":[{"given":"Wei Hsum","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354482","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}